Advanced search
Publication Cover
Future Cardiology Volume 1, 2005 - Issue 6
Submit an article Journal homepage
159
Views
0
CrossRef citations to date
0
Altmetric
Review

Toll-like Receptors and Atherosclerosis: Oxidized Ldl As an Endogenous Toll-like Receptor Ligand

Yury I MillerUniversity of California Department of MedicineSan DiegoUSA. Tel.: +1 858 822 5771; Fax: +1 858 534 2005; [email protected]Correspondence[email protected]
Pages 785-792 | Published online: 25 Oct 2005

Bibiliography

  • Steinberg D , ParthasarathyS, CarewTE, KhooJC, WitztumJL: Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.N. Engl. J. Med., 320, 915–924 (1989).
  • Tsimikas S , BrilakisES, MillerERet al.: Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.N. Engl. J. Med., 353, 46–57 (2005).
  • Binder CJ , ChangMK, ShawPXet al.: Innate and acquired immunity in atherogenesis.Nature Med., 8, 1218–1226 (2002).
  • Miller YI , ChangMK, BinderCJ, ShawPX, WitztumJL: Oxidized low density lipoprotein and innate immune receptors.Curr. Opin. Lipidol., 14, 437–445 (2003).
  • Schonbeck U , LibbyP: Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as anti-inflammatory agents?Circulation, 109, II–18 (2004).
  • Hansson GK : Inflammation, atherosclerosis, and coronary artery disease.N. Engl. J. Med., 352, 1685–1695 (2005).
  • Tobias P , CurtissLK: Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis.J. Lipid Res., 46, 404–411 (2005).
  • Binder CJ , ShawPX, ChangMKet al.: Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis.J. Lipid Res., 46, 1353–1363 (2005).
  • Wright SD , RamosRA, TobiasPS, UlevitchRJ, MathisonJC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.Science, 249, 1431–1433 (1990).
  • Medzhitov R , Preston-HurlburtP, JanewayCA Jr.: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 388, 394–397 (1997).
  • Poltorak A , HeX, SmirnovaIet al.: Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene.Science, 282, 2085–2088 (1998).
  • Johnson GB , RiggsBL, PlattJL: A genetic basis for the ‘Adonis’ phenotype of low adiposity and strong bones.FASEB J., 18, 1282–1284 (2004).
  • Methe H , KimJO, KoflerS, WeisM, NabauerM, KoglinJ: Expansion of circulating toll-like receptor 4-positive monocytes in patients with acute coronary syndrome.Circulation, 111, 2654–2661 (2005).
  • Edfeldt K , SwedenborgJ, HanssonGK, YanZQ: Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.Circulation, 105, 1158–1161 (2002).
  • Xu XH , ShahPK, FaureEet al.: Toll-Like Receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.Circulation, 104, 3103–3108 (2001).
  • Walton KA , HsiehX, Gharavi N et al.: Receptors involved in the Ox-PAPC-mediated synthesis of IL-8: A role for toll-like receptor 4 and a GPI anchored protein. J. Biol. Chem., 278, 29661–29666 (2003).
  • Dunzendorfer S , LeeHK, SoldauK, TobiasPS: Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS-responses.FASEB J.03–1263fje (2004).
  • Dunzendorfer S , LeeHK, TobiasPS: Flow-dependent regulation of endothelial toll-like receptor 2 expression through inhibition of SP1 activity.Circ. Res., 95, 684–691 (2004).
  • Yang X , CoriolanD, MurthyV, SchultzK, GolenbockDT, BeasleyD: Proinflammatory phenotype of vascular smooth muscle cells: Role of efficient toll-like receptor 4 signaling.Am. J. Physiol. Heart Circ. Physiol., 289, 69–76 (2005).
  • Kiechl S , LorenzE, ReindlMet al.: Toll-like receptor 4 polymorphisms and atherogenesis.N. Engl. J. Med., 347, 185–192 (2002).
  • Ameziane N , BeillatT, VerpillatPet al.: Association of the toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events.Arterioscler. Thromb. Vasc. Biol., 23, E61–E64 (2003).
  • Boekholdt SM , AgemaWR, PetersRJet al.: Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events.Circulation, 107, 2416–2421 (2003).
  • Holloway JW , YangIA, YeS: Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction.Pharmacogenet. Genomics, 15, 15–21 (2005).
  • Lin YC , ChangYM, YuJM, YenJH, ChangJG, HuCJ: Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan.Atherosclerosis, 180, 305–309 (2005).
  • Netea MG , HijmansA, VanWSet al.: Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia.Eur. J. Clin. Invest., 34, 94–99 (2004).
  • Yang IA , HollowayJW, YeS: TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis.Atherosclerosis, 170, 187–190 (2003).
  • Reismann P , LichyC, RudofskyGet al.: Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia.J. Neurol., 251, 853–858 (2004).
  • Zee RYL , HegenerHH, GouldJ, RidkerPM: Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis.Stroke, 36, 154–157 (2005).
  • Morange PE , TiretL, SautNet al.: TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study.Eur. J. Hum. Genet., 12, 1041–1049 (2004).
  • Norata GD , GarlaschelliK, OngariMet al.: Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS.J. Intern. Med., 258, 21–27 (2005).
  • Edfeldt K , BennetAM, ErikssonPet al.: Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction.Eur. Heart J., 25, 1447–1453 (2004).
  • Bjorkbacka H , KunjathoorVV, MooreKJet al.: Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nature Med., 10, 416–421 (2004).
  • Akira S , TakedaK: Toll-like receptor signalling.Nature Rev. Immunol., 4, 499–511 (2004).
  • Michelsen KS , WongMH, ShahPKet al.: Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.PNAS, 101, 10679–10684 (2004).
  • Mullick AE , TobiasPS, CurtissLK: Modulation of Atherosclerosis in Mice by Toll-Like Receptor 2.J. Clin. Invest. (In press) (2005).
  • Kol A , LibbyP: The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations.Trends Cardiovasc. Med., 8, 191–199 (1998).
  • O’Connor S , TaylorC, CampbellLA, EpsteinS, LibbyP: Potential infectious etiologies of atherosclerosis: a multifactorial perspective.Emerg. Infect. Dis., 7, 780–788 (2001).
  • Kalayoglu MV , LibbyP, ByrneGI: Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.JAMA, 288, 2724–2731 (2002).
  • Bulut Y , FaureE, ThomasLet al.: Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway.J. Immunol., 168, 1435–1440 (2002).
  • Yaraei K , CampbellLA, ZhuX, LilesWC, Kuo Cc, Rosenfeld ME: Chlamydia pneumoniae augments the oxidized low-density lipoprotein-induced death of mouse macrophages by a caspase-independent pathway. Infect. Immun., 73, 4315–4322 (2005).
  • Scannapieco FA , BushRB, PajuS: Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review.Ann. Periodontol., 8, 38–53 (2003).
  • Gibson FC III, Hong C, Chou HH et al.: Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation, 109, 2801–2806 (2004).
  • Lehr HA , SagbanTA, IhlingCet al.: Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet.Circulation, 104, 914–920 (2001).
  • Ostos MA , RecaldeD, ZakinMM, Scott-AlgaraD: Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation.FEBS Lett., 519, 23–29 (2002).
  • Kazemi MR , McDonaldCM, ShigenagaJK, GrunfeldC, FeingoldKR: Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists.Arterioscler. Thromb. Vasc. Biol., 25, 1220–1224 (2005).
  • Khovidhunkit W , MoserAH, ShigenagaJK, GrunfeldC, FeingoldKR: Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR.J. Lipid Res., 44, 1728–1736 (2003).
  • Park HS , JungHY, ParkEY, KimJ, LeeWJ, BaeYS: Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-κB.J. Immunol., 173, 3589–3593 (2004).
  • Rachmilewitz D , KatakuraK, KarmeliFet al.: Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology, 126, 520–528 (2004).
  • Shaw PX , HörkköS, ChangMKet al.: Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity.J. Clin. Invest., 105, 1731–1740 (2000).
  • Binder CJ , HörkköS, DewanAet al.: Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.Nature Med., 9, 736–743 (2003).
  • Boullier A , FriedmanP, HarkewiczRet al.: Phosphocholine as a pattern recognition ligand for CD36.J. Lipid Res., 46, 969–976 (2005).
  • Hoebe K , GeorgelP, RutschmannSet al.:: CD36 is a sensor of diacylglycerides. Nature, 433, 523–527 (2005).
  • Miller YI , WorrallDS, FunkCD, FeramiscoJR, WitztumJL: Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase.Mol. Biol. Cell, 14, 4196–4206 (2003).
  • Miller YI , ViriyakosolS, BinderCJ, FeramiscoJR, KirklandTN, WitztumJL: Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells.J. Biol. Chem., 278, 1561–1568 (2003).
  • Miller YI , ViriyakosolS, WorrallDS, BoullierA, ButlerS, WitztumJL: Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.Arterioscler. Thromb. Vasc. Biol., 25, 1213–1219 (2005).
  • Schmidt A , CaronE, HallA: Lipopolysaccharide-induced activation of β2-integrin function in macrophages requires Irak kinase activity, p38 mitogen- activated protein kinase, and the Rap1 GTPase.Mol. Cell Biol., 21, 438–448 (2001).
  • West MA , WallinRPA, MatthewsSPet al.: Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling.Science, 305, 1153–1157 (2004).
  • Schrijvers DM , De Meyer GRY, Kockx MM, Herman AG, Martinet W: Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 25, 1256–1261 (2005).
  • Romashkova JA , MakarovSS: NF-κB is a target of AKT in anti-apoptotic PDGF signalling.Nature, 401, 86–90 (1999).
  • Ozes ON , MayoLD, GustinJA, PfefferSR, PfefferLM, DonnerDB: NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase.Nature, 401, 82–85 (1999).
  • Bochkov VN , KadlA, HuberJ, GruberF, BinderBR, LeitingerN: Protective role of phospholipid oxidation products in endotoxin-induced tissue damage.Nature, 419, 77–81 (2002).
  • Chang MK , BergmarkC, LaurilaAet al.: Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition.Proc. Natl Acad. Sci. USA, 96, 6353–6358 (1999).
  • Chang MK , BinderCJ, MillerYIet al.: Apoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory.J. Exp. Med., 200, 1359–1370 (2004).
  • Brunn GJ , BungumMK, JohnsonJB, PlattJL: Conditional signaling by Toll-like receptor 4.FASEB J., 200, 04–3211fje (2005).
  • Johnson GB , BrunnGJ, KodairaY, PlattJL: Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4.J. Immunol., 168, 5233–5239 (2002).
  • Termeer C , BenedixF, SleemanJet al.: Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4.J. Exp. Med., 195, 99–111 (2002).
  • Schaefer L , BabelovaA, KissEet al.: The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages.J. Clin. Invest., 115, 2223–2233 (2005).
  • Okamura Y , WatariM, JerudESet al.: The Extra Domain A of Fibronectin Activates Toll-like Receptor 4.J. Biol. Chem., 276, 10229–10233 (2001).
  • Tan MH , SunZ, OpitzSL, SchmidtTE, PetersJH, GeorgeEL: Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis.Blood, 104, 11–18 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.